Phathom Pharmaceuticals今日正式宣布,已完成其普通股及预先注资认股权证公开发行的定价工作。此次发行规模总计高达1.3亿美元,标志着公司在资本市场的又一重要融资举措。
Phathom Pharmaceuticals今日正式宣布,已完成其普通股及预先注资认股权证公开发行的定价工作。此次发行规模总计高达1.3亿美元,标志着公司在资本市场的又一重要融资举措。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.